Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.26% slid 2.09% to $182.94 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.64% rising 0.09% to 32,832.54 and the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +1.71% falling 0.10% to 12,644.46. This was the stock's second consecutive day of losses. Moderna Inc. closed $314.55 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.72% rose 1.67% to $140.34, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +2.06% rose 0.42% to $247.29, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +2.59% fell 1.38% to $65.12. Trading volume (4.0 M) remained 1.3 million below its 50-day average volume of 5.3 M.